Literature DB >> 21844072

ACCF/AHA 2011 health policy statement on therapeutic interchange and substitution: a report of the American College of Cardiology Foundation Clinical Quality Committee.

David R Holmes, Jeffrey A Becker, Christopher B Granger, Marian C Limacher, Robert Lee Page, Cathy Sila.   

Abstract

Mesh:

Year:  2011        PMID: 21844072     DOI: 10.1161/CIR.0b013e31822d97d5

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  10 in total

1.  Is there a need for a formulary of clinically interchangeable medicines to guide generic substitution in Saudi Arabia?

Authors:  Alian A Alrasheedy; Mohamed Azmi Hassali; Hisham Aljadhey; Mohamed Izham Mohamed Ibrahim; Saleh Karamah Al-Tamimi
Journal:  J Young Pharm       Date:  2013-07-08

2.  Evaluation of discharge medication orders following automatic therapeutic substitution of commonly exchanged drug classes.

Authors:  Sarah Glaholt; Genevieve L Hayes; Christopher S Wisniewski
Journal:  P T       Date:  2014-04

3.  Systematic literature review of the methodology for developing pharmacotherapeutic interchange guidelines and their implementation in hospitals and ambulatory care settings.

Authors:  Maria Adrover-Rigo; Maria-Dolores Fraga-Fuentes; Francesc Puigventos-Latorre; Iciar Martinez-Lopez
Journal:  Eur J Clin Pharmacol       Date:  2018-10-19       Impact factor: 2.953

4.  Impact of generic substitution practice on care of diabetic patients.

Authors:  Olubukola O Oyetunde; Bolajoko A Aina; Fola Tayo
Journal:  Int J Clin Pharm       Date:  2014-04-10

Review 5.  US Food and Drug Administration approval of generic versions of complex biologics: implications for the practicing physician using low molecular weight heparins.

Authors:  Marc Cohen; Walter P Jeske; Jose C Nicolau; Gilles Montalescot; Jawed Fareed
Journal:  J Thromb Thrombolysis       Date:  2012-04       Impact factor: 2.300

6.  ePrescribing: Reducing Costs through In-Class Therapeutic Interchange.

Authors:  Shane P Stenner; Rohini Chakravarthy; Kevin B Johnson; William L Miller; Julie Olson; Marleen Wickizer; Nate N Johnson; Rick Ohmer; David R Uskavitch; Gordon R Bernard; Erin B Neal; Christoph U Lehmann
Journal:  Appl Clin Inform       Date:  2016-12-14       Impact factor: 2.342

Review 7.  Narrow therapeutic index drugs: a clinical pharmacological consideration to flecainide.

Authors:  Juan Tamargo; Jean-Yves Le Heuzey; Phillipe Mabo
Journal:  Eur J Clin Pharmacol       Date:  2015-04-15       Impact factor: 2.953

8.  Evaluating patients' perceptions regarding generic medicines in Jordan.

Authors:  Faris El-Dahiyat; Reem Kayyali
Journal:  J Pharm Policy Pract       Date:  2013-06-13

9.  Post cardiac arrest care and follow-up in Sweden - a national web-survey.

Authors:  Johan Israelsson; Gisela Lilja; Anders Bremer; Jean Stevenson-Ågren; Kristofer Årestedt
Journal:  BMC Nurs       Date:  2016-01-09

10.  The right drug, but from whose perspective? A framework for analysing the structure and activities of drug and therapeutics committees.

Authors:  Mikael Hoffmann
Journal:  Eur J Clin Pharmacol       Date:  2013-05-03       Impact factor: 2.953

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.